Active Biotech
A company with focus on research and development of pharmaceutical products.
Launch date
Employees
Market cap
€15.8m
Enterprise valuation
€12m (Public information from Sep 2024)
Share price
SEK0.3775 ACTI.ST
Lund Municipality Skane County (HQ)
Financials
Estimates*
| SEK | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 6.7m | - | - | - | - | 9.3m | 40.3m |
| % growth | (20 %) | - | - | - | - | - | 333 % |
| EBITDA | (31.1m) | (48.5m) | (56.4m) | (44.5m) | (45.0m) | (41.0m) | (<1m) |
| % EBITDA margin | (462 %) | - | - | - | - | (441 %) | (1 %) |
| Profit | (32.2m) | (49.8m) | (58.4m) | (45.8m) | (45.0m) | (41.0m) | (<1m) |
| % profit margin | (479 %) | - | - | - | - | (441 %) | (1 %) |
| EV / revenue | 40.8x | - | - | - | - | 17.4x | 4.0x |
| EV / EBITDA | -8.8x | -4.6x | -4.5x | -2.9x | -3.9x | -4.0x | -578.9x |
| R&D budget | 25.5m | 34.5m | 42.8m | 32.5m | - | - | - |
| R&D % of revenue | 380 % | - | - | - | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
SEK270m Valuation: SEK270m | Acquisition | ||
| Total Funding | - | ||
Recent News about Active Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.